Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomas
Author:
Publisher
Informa UK Limited
Subject
Pharmacology,Immunology,Immunology and Allergy
Link
http://www.tandfonline.com/doi/pdf/10.4161/hv.23970
Reference47 articles.
1. Cancer vaccines in phase II/III clinical trials: state of the art and future perspectives;Cecco;Curr Cancer Drug Targets,2011
2. Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma;Schuster;J Clin Oncol,2011
3. Identifying patients with follicular lymphoma who are likely to benefit from an idiotype vaccine;Ansell;J Clin Oncol,2011
4. The paradox of response and survival in cancer therapeutics;Huff;Blood,2006
5. Idiotype vaccination as consolidation therapy: time for integration into standard of care for follicular lymphoma?;Schuster;J Clin Oncol,2011
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Personalized Medicine in Oncology Drug Development;Holland‐Frei Cancer Medicine;2019-12-06
2. Recent progress in GM-CSF-based cancer immunotherapy;Immunotherapy;2017-03
3. Personalized Medicine in Oncology Drug Development;Holland‐Frei Cancer Medicine;2017-02-26
4. The role of novel immunotherapies in non-Hodgkin lymphoma;Translational Cancer Research;2017-02
5. NK Cell Activation in the Antitumor Response Induced by IFN-α Dendritic Cells Loaded with Apoptotic Cells from Follicular Lymphoma Patients;The Journal of Immunology;2016-06-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3